📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
17
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
42%
🔁 Convertible Conversion
60%
• Major convertible overhang: 33% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split
30%
• 50-day avg $1.71 approaching $1 threshold
💰 Capital Raise
18%
• Active ATM program with $50M remaining capacity
💹 Market Data
Market Cap$245.26M
Shares Outstanding154.25M
Float132.53M
Cash$167.05M
Debt$54.37M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.7% shares (2025Q4 vs prior)
127 institutional holders · 52.49M shares
#1
BlackRock, Inc.
10.56M shares
#2
VANGUARD GROUP INC
10.03M shares
#3
Kohlberg Kravis Roberts & Co. L.P.
3.04M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest28.11M
Days to Cover17.2
% of Float21.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
xbrl
XBRL WARRANT
Dec 31, 2014
8-K
8K EVENT
Feb 17, 2026
424B5
ATM
Feb 13, 2026
424B5
ATM
Feb 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CHRS
📊 CHRS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CHRS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.